Startups channel feed – Endpoints News

Startups channel feed

With lessons learned from Vor, Siddhartha Mukherjee takes a different route to target solid tumors with startup Myeloid

5 years ago

A veteran oncology startup crew is making a very serious bet that they’ve found the key to unlocking the promise of oncolytic viruses

5 years ago

Taysha Gene Therapies looks to build on rapid IPO with $85M dev-manufacturing plant in North Carolina

5 years ago

Updated: Neuron23 launches with $113M financing and eyes dead set on Denali and Biogen

5 years ago

Out of CRISPR pioneer David Liu's lab comes a small molecule play targeting exosites — and it's raised a modest $25M to push toward clinic

5 years ago

Faze Medicines launches with $81M Series A, Alnylam vet heading science in play at biomolecular condensates

5 years ago

'Scale and speed': Hillhouse puts its weight behind China startup eyeing cutting-edge tech from around the world

5 years ago

Vigil Neuroscience launches with a $50M Series A and two former Amgen neuroscience candidates

5 years ago

GlaxoSmithKline R&D vet Min Li nabs $100M to launch a Bob Nelsen-backed startup focused on China’s burgeoning neuro market

5 years ago

Is there room for a new way to drug RNA? ARCH, Foresite join Atlas, The Column Group for $81M bet

5 years ago

Maze Therapeutics spins out two new companies with Alloy and BridgeBio

5 years ago

Roche shelved these psychiatry drugs. So its former head of neuro cooked up some new plans — and raised $59M for his startup

5 years ago

Kinaset launches with $40M and a JAK inhibitor from Vectura's old pipeline

5 years ago

After 5 quiet years, a former Scripps spinout raises $200M and announces plans to try again at an IPO

5 years ago

Bob Nelsen raises $800M and recruits a star-studded board to build the 'Foxconn' of biotech

5 years ago

George Church backs a startup solution to the massive gene therapy manufacturing bottleneck

5 years ago

An Oxford spinout raises $44M as it looks to resurrect an old Roche antibody in pursuit of a rare disease

5 years ago

MPM, DCVC Bio back $53M round for a bold concept: Let patients make their own CAR-T in vivo

5 years ago

Elevation Oncology bags $65M to push failed Merrimack drug through PhII

5 years ago

Here's a $200M China startup idea — if you can read beyond the big words

5 years ago

One of biotech's flashiest startups is finally getting some competition from a pioneer in a brand new field

5 years ago

A pharma R&D chief jumps to a budding new startup factory — and this time he’s found 'something completely different’

5 years ago

Chasing a 'master modulator' in the endocannabinoid system, biotech upstart promises to shake up neuropsychiatric treatments

5 years ago

Kira Pharmaceuticals emerges from stealth with $46M and new CEO to lead complement therapy mission

5 years ago

First page Previous page 48 49 505152 53 54 Next page Last page